Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. A 64077
2. A-64077
3. Abbot 64077
4. N-(1-benzo(b)thien-2-ylethyl)-n-hydroxyurea
5. Zyflo
1. 111406-87-2
2. Zyflo
3. Leutrol
4. 1-(1-(benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea
5. Zileutonum
6. Abbott 64077
7. Zileutonum [inn-latin]
8. 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea
9. A-64077
10. N-(1-benzo(b)thien-2-ylethyl)-n-hydroxyurea
11. A 64077
12. Zyflo (tn)
13. Abbott-64077
14. Urea, N-(1-benzo[b]thien-2-ylethyl)-n-hydroxy-
15. Chembl93
16. 1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea
17. Nsc-730712
18. Nsc-759277
19. N-[1-(benzo[b]thiophen-2-yl)ethyl]-n-hydroxyurea
20. V1l22wve2s
21. (+-)-1-(1-benzo(b)thien-2-ylethyl)-1-hydroxyurea
22. (+/-)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea
23. Zyflo Cr
24. Chebi:10112
25. N-(1-benzo[b]thien-2-ylethyl)-n-hydroxyurea
26. (+-)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea
27. N-(1-benzo(b)thien-2-yl-ethyl)-n-hydroxyurea
28. Ncgc00159453-02
29. Dsstox_cid_3752
30. Dsstox_rid_77185
31. Dsstox_gsid_23752
32. Urea, N-(1-benzo(b)thien-2-ylethyl)-n-hydroxy-
33. Ziluton
34. Zyflo Filmtab
35. ( Inverted Exclamation Marka)-1(1-benzo[b]thien-2-ylethyl)-1-hydroxyure
36. Smr000466377
37. Cas-111406-87-2
38. Zileuton (usp/inn)
39. Sr-01000759349
40. (+/-)-1-(1-benzo(b)thien-2-ylethyl)-1-hydroxyurea
41. Unii-v1l22wve2s
42. Cti-02
43. Abt-077
44. Zileuton [usan:usp:inn:ban]
45. Zileuton- Bio-x
46. Mfcd00866097
47. Starbld0016861
48. Zileuton [usan]
49. Zileuton [inn]
50. Zileuton [mi]
51. Zileuton [vandf]
52. Prestwick0_001090
53. Zileuton [mart.]
54. Zileuton [usp-rs]
55. Zileuton [who-dd]
56. Schembl4209
57. Mls000759510
58. Mls001424079
59. Mls006011971
60. Zileuton [orange Book]
61. Gtpl5297
62. Zileuton, >=98% (hplc)
63. Dtxsid9023752
64. Schembl18251470
65. Zileuton [usp Monograph]
66. Urea, N-(1-benzo(b)thien-2-ylethyl)-n-hydroxy-, (+-)-
67. Hms2051m20
68. Hms2089j12
69. Hms2093h06
70. Hms2235o04
71. Hms3369i17
72. Hms3393m20
73. Hms3654j08
74. Hms3714e07
75. Hms3872f13
76. Pharmakon1600-01505906
77. Amy12540
78. Bcp16199
79. Tox21_111680
80. Tox21_301148
81. Bbl029070
82. Bdbm50000541
83. Nsc730712
84. Nsc759277
85. S1443
86. Stl373010
87. Akos000280127
88. Akos016340558
89. Tox21_111680_1
90. Ccg-100901
91. Ccg-213571
92. Cs-1563
93. Db00744
94. Ks-1195
95. Nc00151
96. Nsc 730712
97. Nsc 759277
98. Sb19083
99. Mrf-0000030
100. Ncgc00159453-03
101. Ncgc00159453-04
102. Ncgc00159453-05
103. Ncgc00159453-06
104. Ncgc00255046-01
105. Ac-13198
106. Ac-31490
107. Bz164573
108. Hy-14164
109. Sbi-0206869.p001
110. Db-015071
111. Bb 0261152
112. Ft-0601582
113. Ft-0675903
114. Sw197531-3
115. 1-(1-benzothiophen-2-ylethyl)-1-hydroxy-urea
116. D00414
117. N-(1-benzo[b]thien-2-ylethyl)-n-hydroxy-urea
118. Ab00639921-06
119. Ab00639921-08
120. Ab00639921-09
121. Ab00639921_10
122. Ab00639921_11
123. 406z872
124. A802357
125. Q202998
126. J-002574
127. J-525169
128. Sr-01000759349-4
129. Sr-01000759349-5
130. Sr-01000759349-6
131. Zileuton, Commercially Available As 600 Mg Tablets
132. Brd-a56359832-001-04-6
133. Z1551429725
134. Zileuton, United States Pharmacopeia (usp) Reference Standard
135. Urea, N-(1-benzo(b)thien-2-ylethyl)-n-hydroxy-, (+/-)-
Molecular Weight | 236.29 g/mol |
---|---|
Molecular Formula | C11H12N2O2S |
XLogP3 | 1.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 236.06194880 g/mol |
Monoisotopic Mass | 236.06194880 g/mol |
Topological Polar Surface Area | 94.8 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 275 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Zyflo |
PubMed Health | Zileuton (By mouth) |
Drug Classes | Anti-Inflammatory |
Drug Label | Zileuton is an orally active inhibitor of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Zileuton has the chemical name ()-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea and the following chemical struct... |
Active Ingredient | Zileuton |
Dosage Form | Tablet |
Route | Oral |
Strength | 600mg |
Market Status | Prescription |
Company | Chiesi Usa |
2 of 4 | |
---|---|
Drug Name | Zyflo cr |
PubMed Health | Zileuton (By mouth) |
Drug Classes | Anti-Inflammatory |
Drug Label | Zileuton is an orally active inhibitor of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Zileuton has the chemical name ()-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea and the following chemical struct... |
Active Ingredient | Zileuton |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 600mg |
Market Status | Prescription |
Company | Chiesi Usa |
3 of 4 | |
---|---|
Drug Name | Zyflo |
PubMed Health | Zileuton (By mouth) |
Drug Classes | Anti-Inflammatory |
Drug Label | Zileuton is an orally active inhibitor of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Zileuton has the chemical name ()-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea and the following chemical struct... |
Active Ingredient | Zileuton |
Dosage Form | Tablet |
Route | Oral |
Strength | 600mg |
Market Status | Prescription |
Company | Chiesi Usa |
4 of 4 | |
---|---|
Drug Name | Zyflo cr |
PubMed Health | Zileuton (By mouth) |
Drug Classes | Anti-Inflammatory |
Drug Label | Zileuton is an orally active inhibitor of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Zileuton has the chemical name ()-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea and the following chemical struct... |
Active Ingredient | Zileuton |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 600mg |
Market Status | Prescription |
Company | Chiesi Usa |
For the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.
FDA Label
Zileuton is an asthma drug that differs chemically and pharmacologically from other antiasthmatic agents. It blocks leukotriene synthesis by inhibiting 5-lipoxygenase, an enzyme of the eicosanoid synthesis pathway. Current data indicates that asthma is a chronic inflammatory disorder of the airways involving the production and activity of several endogenous inflammatory mediators, including leukotrienes. Sulfido-peptide leukotrienes (LTC4, LTD4, LTE4, also known as the slow-releasing substances of anaphylaxis) and LTB4, a chemoattractant for neutrophils and eosinophils, are derived from the initial unstable product of arachidonic acid metabolism, leukotriene A4 (LTA4), and can be measured in a number of biological fluids including bronchoalveolar lavage fluid (BALF) from asthmatic patients. In humans, pretreatment with zileuton attenuated bronchoconstriction caused by cold air challenge in patients with asthma.
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Lipoxygenase Inhibitors
Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)
Leukotriene Antagonists
A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)
Absorption
Rapidly and almost completely absorbed. The absolute bioavailability is unknown.
Route of Elimination
Elimination of zileuton is predominantly via metabolism with a mean terminal half-life of 2.5 hours. The urinary excretion of the inactive N-dehydroxylated metabolite and unchanged zileuton each accounted for less than 0.5% of the dose.
Volume of Distribution
1.2 L/kg
Clearance
Apparent oral cl=7 mL/min/kg
Hepatic. Zileuton and its N-dehydroxylated metabolite are oxidatively metabolized by the cytochrome P450 isoenzymes 1A2, 2C9 and 3A4.
Zileuton has known human metabolites that include Zileuton O-glucuronide.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
2.5 hours
Leukotrienes are substances that induce numerous biological effects including augmentation of neutrophil and eosinophil migration, neutrophil and monocyte aggregation, leukocyte adhesion, increased capillary permeability, and smooth muscle contraction. These effects contribute to inflammation, edema, mucus secretion, and bronchoconstriction in the airways of asthmatic patients. Zileuton relieves such symptoms through its selective inhibition of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Specifically, it inhibits leukotriene LTB4, LTC4, LTD4, and LTE4 formation. Both the R(+) and S(-) enantiomers are pharmacologically active as 5-lipoxygenase inhibitors in in vitro systems. Due to the role of leukotrienes in the pathogenesis of asthma, modulation of leukotriene formation by interruption of 5-lipoxygenase activity may reduce airway symptoms, decrease bronchial smooth muscle tone, and improve asthma control.
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm : D-24 and D24/1 MIDC Kurkumbh Tal. Daund, Dist Pune 413 802, Maharashtra State
Date of Issue : 2022-06-17
Valid Till : 2025-07-14
Written Confirmation Number : WC-0021n
Address of the Firm : Sy. Nos: 317, 320, 321, 322, 323, 604 & 605, Rudraram (Village), Patancheru (Man...
Date of Issue : 2020-07-23
Valid Till : 2023-05-11
Written Confirmation Number : WC-0273
Address of the Firm : Plot No. 34A, J.N.Pharma City, Thanam (V), Parawada (M), Vishakhapatnam-District...
Date of Issue : 2022-09-30
Valid Till : 2025-08-04
Written Confirmation Number : WC-0127
Address of the Firm : A1/B, SIPCOT Industrial Complex, Kudikadu, Cuddalore-607 005
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Zileuton manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zileuton, including repackagers and relabelers. The FDA regulates Zileuton manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zileuton API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zileuton manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zileuton supplier is an individual or a company that provides Zileuton active pharmaceutical ingredient (API) or Zileuton finished formulations upon request. The Zileuton suppliers may include Zileuton API manufacturers, exporters, distributors and traders.
click here to find a list of Zileuton suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zileuton DMF (Drug Master File) is a document detailing the whole manufacturing process of Zileuton active pharmaceutical ingredient (API) in detail. Different forms of Zileuton DMFs exist exist since differing nations have different regulations, such as Zileuton USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zileuton DMF submitted to regulatory agencies in the US is known as a USDMF. Zileuton USDMF includes data on Zileuton's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zileuton USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zileuton suppliers with USDMF on PharmaCompass.
A Zileuton written confirmation (Zileuton WC) is an official document issued by a regulatory agency to a Zileuton manufacturer, verifying that the manufacturing facility of a Zileuton active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zileuton APIs or Zileuton finished pharmaceutical products to another nation, regulatory agencies frequently require a Zileuton WC (written confirmation) as part of the regulatory process.
click here to find a list of Zileuton suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zileuton as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zileuton API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zileuton as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zileuton and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zileuton NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zileuton suppliers with NDC on PharmaCompass.
Zileuton Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zileuton GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zileuton GMP manufacturer or Zileuton GMP API supplier for your needs.
A Zileuton CoA (Certificate of Analysis) is a formal document that attests to Zileuton's compliance with Zileuton specifications and serves as a tool for batch-level quality control.
Zileuton CoA mostly includes findings from lab analyses of a specific batch. For each Zileuton CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zileuton may be tested according to a variety of international standards, such as European Pharmacopoeia (Zileuton EP), Zileuton JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zileuton USP).
LOOKING FOR A SUPPLIER?